A detailed history of Bvf Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Bvf Inc holds 7,000,000 shares of ANNX stock, worth $45.9 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
7,000,000
Previous 7,000,000 -0.0%
Holding current value
$45.9 Million
Previous $50.2 Million 31.66%
% of portfolio
1.05%
Previous 1.5%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $11.4 Million - $32.4 Million
7,000,000 New
7,000,000 $31.8 Million
Q2 2022

Aug 15, 2022

BUY
$2.11 - $4.06 $7.98 Million - $15.3 Million
3,780,694 New
3,780,694 $14.3 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $312M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.